Evaluation of Cardiac Compass With OptiVol in the Early Detection of Decompensation Events for Heart Failure
Public ClinicalTrials.gov record NCT00510198. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
PRECEDE-HF -Prospective, Randomized Evaluation of Cardiac Compass With OptiVol in the Early Detection of Decompensation Events for Heart Failure
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the PRECEDE-HF study is to collect data to compare patients whose heart failure is managed using Cardiac Compass with OptiVol (which is a tool in the device that records information about the heart that doctors can use to help treat their heart disease) combined with standard treatment methods (Access Group) to patients whose heart failure is managed by standard treatment methods only (Control Group). This comparison will show if the additional monitoring provided by Cardiac Compass with OptiVol delays the time patients are first admitted to hospital for heart failure or delays the time to death.
Study identification
- NCT ID
- NCT00510198
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Not applicable
- Enrollment
- 120 participants
Conditions and interventions
Conditions
Interventions
- Cardiac Compass with OptiVol Fluid Status Monitoring Device
- Standard of Care alone (clinical assessment) Device
Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2007
- Primary completion
- Mar 31, 2009
- Completion
- Mar 31, 2009
- Last update posted
- Apr 9, 2019
2007 – 2009
United States locations
- U.S. sites
- 33
- U.S. states
- 23
- U.S. cities
- 33
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Anchorage | Alaska | 99508 | — |
| Not listed | Little Rock | Arkansas | 72205 | — |
| Not listed | Berkeley | California | 94705 | — |
| Not listed | Larkspur | California | 94939 | — |
| Not listed | Colorado Springs | Colorado | 80909 | — |
| Not listed | Fort Collins | Colorado | 80528 | — |
| Not listed | Jacksonville | Florida | 32207 | — |
| Not listed | Atlanta | Georgia | 30306 | — |
| Not listed | Kankakee | Illinois | 60901 | — |
| Not listed | Oak Lawn | Illinois | 60453 | — |
| Not listed | Rockford | Illinois | 61107 | — |
| Not listed | Indianapolis | Indiana | 46260 | — |
| Not listed | Louisville | Kentucky | 40205 | — |
| Not listed | New Orleans | Louisiana | 70121 | — |
| Not listed | Takoma Park | Maryland | 20912 | — |
| Not listed | Springfield | Massachusetts | 01199 | — |
| Not listed | Saginaw | Michigan | 48601 | — |
| Not listed | Ypsilanti | Michigan | 48197 | — |
| Not listed | Saint Cloud | Minnesota | 56303 | — |
| Not listed | Saint Joseph | Missouri | 64501 | — |
| Not listed | St Louis | Missouri | 63110 | — |
| Not listed | Albany | New York | 12212 | — |
| Not listed | Akron | Ohio | 44304 | — |
| Not listed | Cleveland | Ohio | 44195 | — |
| Not listed | Columbus | Ohio | 43210 | — |
| Not listed | Elyria | Ohio | 44035 | — |
| Not listed | Oklahoma City | Oklahoma | 73120 | — |
| Not listed | Doylestown | Pennsylvania | 18901 | — |
| Not listed | Lancaster | Pennsylvania | 17603 | — |
| Not listed | Nashville | Tennessee | 37205 | — |
| Not listed | Austin | Texas | 78705 | — |
| Not listed | Richmond | Virginia | 23294 | — |
| Not listed | Milwaukee | Wisconsin | 53215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00510198, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 9, 2019 · Synced Sep 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00510198 live on ClinicalTrials.gov.